CD 10899, a hydroxylated metabolite of Volasertib, is pharmacologically active against Polo-like kinase 1 (PLK1) with an IC50 of 6 nM. Volasertib is an orally active, highly potent, and ATP-competitive PLK1 inhibitor. CD 10899 can be used for cancer research [1].
Molecular Weight:
634.81
CAS Number:
[1331770-20-7]
Formula:
C34H50N8O4
Target:
PLK
* VAT and and shipping costs not included. Errors and price changes excepted
